TL
ABMD

Tirschwell & Loewy’s Abiomed Inc ABMD Stock Holding History

Tirschwell & Loewy’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$21.1M Buy
73,941
+90
+0.1% +$29.9K 2.89% 16
2018
Q4 		$24M Sell
73,851
-29
-0% -$10.1K 3.64% 11
2018
Q3 		$33.2M Sell
73,880
-60
-0.1% -$23.7K 4.15% 7
2018
Q2 		$30.2M Sell
73,940
-6,240
-8% -$2.26M 4.02% 8
2018
Q1 		$23.3M Sell
80,180
-455
-0.6% -$115K 3.21% 12
2017
Q4 		$15.1M Sell
80,635
-520
-0.6% -$97.1K 2.13% 22
2017
Q3 		$13.7M Buy
81,155
+125
+0.2% +$18.9K 2.07% 23
2017
Q2 		$11.6M Buy
81,030
+325
+0.4% +$43.7K 1.82% 26
2017
Q1 		$10.1M Buy
80,705
+290
+0.4% +$33.6K 1.64% 26
2016
Q4 		$9.06M Sell
80,415
-2,010
-2% -$233K 1.62% 25
2016
Q3 		$10.6M Sell
82,425
-375
-0.5% -$44.9K 1.76% 23
2016
Q2 		$9.05M Sell
82,800
-1,470
-2% -$146K 1.58% 26
2016
Q1 		$7.99M Buy
84,270
+3,655
+5% +$309K 1.4% 29
2015
Q4 		$7.28M Buy
+80,615
New +$6.84M 1.28% 29

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Tirschwell & Loewy's ABMD Position: Q1 2019 in Review

Tirschwell & Loewy increased its Abiomed Inc (ABMD) stake by 0.12% in Q1 2019, buying an estimated $29.9K and bringing the position to 73,941 shares worth $21.1M. The position accounts for 2.89% of the portfolio, ranked #16.

Tirschwell & Loewy first reported a position in ABMD in Q4 2015 and has held it in 14 quarters since. The position peaked at $33.2M in Q3 2018. 559 funds tracked by Wall St. Rank hold ABMD as of Q1 2019.

  • Tirschwell & Loewy held 73,941 shares of Abiomed Inc worth $21.1M as of Q1 2019.
  • Tirschwell & Loewy bought 90 Abiomed Inc shares in Q1 2019, an estimated $29.9K.
  • Abiomed Inc made up 2.89% of Tirschwell & Loewy's portfolio in Q1 2019, its #16 holding.
  • Tirschwell & Loewy first reported a position in Abiomed Inc in Q4 2015 and has held it in 14 quarters since.
  • Tirschwell & Loewy's Abiomed Inc position peaked at $33.2M in Q3 2018.
  • 559 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2019.

Based on Tirschwell & Loewy's 13F filing for Q1 2019, filed 3 Apr 2019.